Home >> News & Media
News & Media          
 

News & Media

 Press Releases and
 Company News
   Events and
 Presentations
   BiondVax in the News
   Press Kit
Press Releases & Company News

 2010
       
17 August 2010 BiondVax Announces Receipt of Ethics ('Helsinki') Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine

English
       
28 July 2010 Frost & Sullivan Awards '2010 European Influenza Vaccines Technology Innovation Award' to BiondVax Pharmaceuticals for Universal Influenza Vaccine

English
       
14 June 2010 BiondVax to Present Universal Flu Vaccine Data at Two Upcoming BioPharma Industry Conferences

English
       
9 June 2010 BiondVax Awarded $1 Million Universal Flu Vaccine Grant from Israeli Office of the Chief Scientist

English
       
28 April 2010 Second successful Phase I/II Clinical Trial for BiondVax’s Universal Flu Vaccine

English
       
8 March 2010 BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial

English
       
24 February 2010 BiondVax enters into Term Sheet to secure up to $ 7 Million through a 3 year Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors

English
       
       
 2009
       
9 December 2009 Successful Stock Offering

English
       
7 December 2009 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals’ Universal Flu Vaccine

English
       
4 October 2009 Wayne Rudolph Appointed Vice President of Corporate Development at BiondVax

English
       
7 September 2009 BiondVax will Begin an Additional Clinical Trial: will Examine the Safety of the Universal Flu Vaccine for the Elderly Population English
       
25 August 2009 Antibodies for the Swine Flu Virus were Found in the Blood of Mice Injected with BiondVax's Universal Vaccine English
       
3 August 2009 Successful Safety Data for BiondVax Even at the Highest Dose of the Universal Flu Vaccine English
       
19 July 2009 Success in the Safety Data of 24 Participants in BiondVax's Clinical Trial for a Universal Flu Vaccine; Proceeds to Injection at the Highest Dose English
       
5 July 2009 Successful Safety Results in the First Participant Group in BiondVax's Clinical Trial for a Universal Flu Vaccine; the Clinical Trial will be Expanded English